RVNC

Revance Therapeutics, Inc.

Delisted

RVNC was delisted on the 5th of February, 2025.

80 hedge funds and large institutions have $301M invested in Revance Therapeutics, Inc. in 2014 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 40 increasing their positions, 19 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
80
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$20.1M
2 +$5.2M
3 +$2.95M
4
AllianceBernstein
AllianceBernstein
Tennessee
+$2.74M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$2.23M

Top Sellers

1 -$21.4M
2 -$15.9M
3 -$12.3M
4
DM
Deerfield Management
New York
-$8.72M
5
Zurich Cantonal Bank
Zurich Cantonal Bank
Switzerland
-$4.42M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$88.8M
2
$26.8M
3
$19.9M
4
$15.3M
5
$13.6M
6
$13.3M
7
$10.9M
8
$9.97M
9
$8.22M
10
$8.15M
11
$7.51M
12
$7.27M
13
$6.15M
14
$5.78M
15
$5.38M
16
$4.53M
17
$3.9M
18
$3.86M
19
$2.98M
20
$2.51M
21
$2.04M
22
$1.91M
23
$1.82M
24
$1.78M
25
$1.76M